Validity and Reliability of the Turkish Version of WOOS

April 15, 2021 updated by: Şeyda ÖZAL, Gazi University

Validity and Reliability of the Turkish Version of Western Ontario Osteoarthritis of the Shoulder Index

Various clinical scales are available to investigate shoulder diseases. Some of them, culturally adapted to the Turkish population. However, none of them are specific for osteoarthritis of the shoulder. Thus, this study aimed to translate the WOOS index into Turkish and investigate its psychometric properties in the Turkish population.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Purpose; The aim of this study is to adapt the Western Ontario Osteoarthritis of the Shoulder Index (WOOS) specific to shoulder osteoarthritis, to Turkish and evaluate its validity and reliability.

Methods; WOOS index was translated and culturally adapted to Turkish, systematically. It was applied to 68 patients with osteoarthritis of the shoulder treated conservatively. The reliability of the scale was checked through internal consistency and test-retest methods. Internal consistency was analyzed with Cronbach's alpha value. Test-retest reliability was assessed using an intraclass correlation coefficient with 25 patients. The Western Ontario Rotator Cuff (WORC), The Shoulder Pain and Disability Index (SPADI), and The Society of American Shoulder and Elbow Surgeons Standardized Shoulder Assessment (ASES) score were used to conduct concurrent validity.

Study Type

Observational

Enrollment (Actual)

68

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Ankara, Turkey, 006560
        • Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, Department of Orthopaedics & Traumatology
      • Ankara, Turkey, 06230
        • Ankara Training and Research Hospital, Department of Orthopaedics & Traumatology
      • Ankara, Turkey, 06560
        • Gazi University Faculty of Health Sciences Physiotherapy and Rehabilitation Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult male and female patients with osteoarthritis of the shoulder

Description

Inclusion Criteria:

  • Presence of the shoulder osteoarthritis, to be a native Turkish speaker

Exclusion Criteria:

  • Illiteracy, cognitive impairment, presence of shoulder circumference fractures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Western Ontario Osteoarthritis of the Shoulder Index, patients get a minimum of 0 points (best condition) and a maximum of 1900 points (worst condition) on this scale.
Time Frame: 1st day
patient administered, spesific to osteoarthritis of shoulder, multisectional questionnaire
1st day
Western Ontario Osteoarthritis of the Shoulder Index, patients get a minimum of 0 points (best condition) and a maximum of 1900 points (worst condition) on this scale.
Time Frame: 2 days later
patient administered, spesific to osteoarthritis of shoulder, multisectional questionnaire
2 days later
The Western Ontario Rotator Cuff Index, patients get a minimum of 0 points (best condition) and a maximum of 2100 points (worst condition) on this scale.
Time Frame: 1st day
patient administered, spesific to rotator cuff disease, multisectional questionnaire
1st day
The Shoulder Pain and Disability Index, patients get a minimum of 0 points (best condition) and a maximum of 100 points (worst condition) on this scale.
Time Frame: 1st day
patient administered, spesific to upper limp, two sectional questionnaire
1st day
The Society of American Shoulder and Elbow Surgeons Standardized Shoulder Assessment, patients get a minimum of 0 points (worst condition) and a maximum of 100 points (best condition) on this scale.
Time Frame: 1st day
patient administered, spesific to upper limp, two sectional questionnaire
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Gazi University

Investigators

  • Principal Investigator: Nevin A GÜZEL, Prof, Gazi University Faculty of Health Sciences
  • Study Chair: Şeyda ÖZAL, MSc, Gazi University Faculty of Health Sciences
  • Study Chair: Ahmet Y KAPTAN, MD, Dr. Sami Ulus Hospital
  • Study Chair: Nihan KAFA, Assc Prof, Gazi University Faculty of Health Sciences
  • Study Chair: Toygun K EREN, MD, Ankara Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 4, 2017

Primary Completion (Actual)

January 10, 2020

Study Completion (Actual)

March 15, 2020

Study Registration Dates

First Submitted

April 27, 2020

First Submitted That Met QC Criteria

April 30, 2020

First Posted (Actual)

May 4, 2020

Study Record Updates

Last Update Posted (Actual)

April 19, 2021

Last Update Submitted That Met QC Criteria

April 15, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Gazi Unv

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe